| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/16/2003 | EP1246809B1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 07/16/2003 | EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders |
| 07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0975354A4 Ligand/lytic peptide compositions and methods of use |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | EP0814793B1 Prilocaine and hydrofluorocarbon aerosol preparations |
| 07/16/2003 | EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/16/2003 | EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 07/16/2003 | EP0550550B1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430603A Novel bicyclic compounds |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430596A New gamma selective retinoids |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1430516A Crystal structures of P-selectin, P-and E-selectin complexes and use thereof |
| 07/16/2003 | CN1430513A Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia |
| 07/16/2003 | CN1430511A Method of improving survival of patients |
| 07/16/2003 | CN1430474A Tryptophan source from plants and uses therefor |
| 07/16/2003 | CN1429911A Slow virus carrier system, method of producing carrier and its application |
| 07/16/2003 | CN1429622A Radix rhodiolae double action lozenge |
| 07/16/2003 | CN1429608A Formula for treating neck lymphadenopathy |
| 07/16/2003 | CN1429595A Domestic fowl auxin containing composite vitamins |
| 07/16/2003 | CN1429593A Domestic fowl auxin containing minerals |
| 07/16/2003 | CN1429581A Liquid medicine for treating postpartum fever |
| 07/16/2003 | CN1429551A Treating diabetes by thiazolidine-diketo and dimethylbiguanide |
| 07/16/2003 | CN1429548A Medicine for treating disease related to low cyclo GMP level |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/16/2003 | CN1114592C Crystalline forms of osanetant |
| 07/16/2003 | CN1114404C Treatment of diabetes with thiazolidinedione and melbine |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/16/2003 | CN1114401C Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament |
| 07/15/2003 | US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes |
| 07/15/2003 | US6593482 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the |
| 07/15/2003 | US6593354 Substituted benzoxazole compounds |
| 07/15/2003 | US6593353 p53 inhibitors and therapeutic use of the same |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593342 Pharmaceutical compositions comprising 2-quinolones |
| 07/15/2003 | US6593337 Tricyclic compounds useful as HIV reverse transcriptase inhibitors |
| 07/15/2003 | US6593336 Methods for treating irritable bowel syndrome |
| 07/15/2003 | US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's |
| 07/15/2003 | US6593332 Phosphodiesterase inhibitors; sexual disorders |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593325 Method for the treatment of anxiety which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1 or a pharmaceutically acceptable salt thereof. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593313 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 07/15/2003 | US6593310 Add to a mammal in need of such treatment an effective amount, typically in the range of 0.1 to 100 micrograms per kg of body weight, of a compound capable of maintaining the integrity of connective tissue, for example pentosan polysulfate. |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization |
| 07/15/2003 | US6593290 Treatment of inner ear hair cells |
| 07/15/2003 | US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds |
| 07/15/2003 | US6593104 Isolated nucleic acid encoding a polypeptide of given amino acid sequence except for an arginine to tryptophan substitution; age-related vision defects |
| 07/15/2003 | US6592902 Controlled release eplerenone compositions |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592843 Liposome mixture containing chelator solution and alpha particle emitting radionuclides; cancer therapy |
| 07/15/2003 | CA2262269C Treatment of skeletal disorders |
| 07/15/2003 | CA2245938C Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 07/15/2003 | CA2139864C Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant |
| 07/15/2003 | CA2059817C Polyamine thiols as radioprotective agents |
| 07/10/2003 | WO2003056013A1 TGF-β-SPECIFIC COVALENTLY CLOSED ANTISENSE MOLECULE |
| 07/10/2003 | WO2003056005A1 Human sglt homolog promoter and use thereof |
| 07/10/2003 | WO2003055980A2 Il-17 like molecules and uses thereof |
| 07/10/2003 | WO2003055918A1 Negatively charged polysaccharide derivable from aloe vera |
| 07/10/2003 | WO2003055915A2 Human netrin receptor and uses thereof |
| 07/10/2003 | WO2003055913A2 Secreted protein |
| 07/10/2003 | WO2003055912A2 Secreted proteins |
| 07/10/2003 | WO2003055901A1 Novel peptide sy |
| 07/10/2003 | WO2003055883A1 Pyrimidotriazines as phosphatase inhibitors |
| 07/10/2003 | WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 07/10/2003 | WO2003055880A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3 |
| 07/10/2003 | WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 07/10/2003 | WO2003055875A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/10/2003 | WO2003055874A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/10/2003 | WO2003055873A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 07/10/2003 | WO2003055871A1 DECAHYDRONAPHTHO[2,3-c]FURAN DERIVATIVES |
| 07/10/2003 | WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | WO2003055865A1 Quinazolinone derivative |
| 07/10/2003 | WO2003055863A1 Novel alkansulfonamides as endothelin antagonists |
| 07/10/2003 | WO2003055860A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 07/10/2003 | WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |